Syndromes with involvement of multiple cranial nerves: An overview

Rissardo, Jamir Pitton; Caprara, AnaLetícia Fornari

doi:10.4103/ijmbs.ijmbs_87_19

Cited by 3 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These sinuses are responsible for draining blood from the brain. Thrombosis can lead to increased pressure inside the skull, potentially resulting in various neurological symptoms [170]. While CVST primarily manifests with symptoms related to increased intracranial pressure, such as headaches, visual disturbances, and seizures, movement disorders are not considered a primary feature of this condition [171].…”

Section: Cerebral Venous Sinus Thrombosismentioning

confidence: 99%

A Literature Review of Movement Disorder Associated with Medications and Systemic Diseases

Pitton Rissardo,

Fornari Caprara

2024

Preprint

View full text Add to dashboard Cite

Movement disorders can be associated with various drugs and systemic diseases, posing diagnostic challenges for clinicians. This review explores the spectrum of movement disorders associated with pharmacological agents and medical conditions. Drug-induced movement disorders encompass a broad range of conditions resulting from exposure to medications that affect several neurotransmitters. Neuroleptic medications can lead to tardive dyskinesia, characterized by involuntary, repetitive movements. Antipsychotics and antiemetics, including metoclopramide, may induce acute dystonic reactions. Other drugs, such as dopamine receptor-blocking agents, can contribute to drug-induced parkinsonism. Beyond medications, movement disorders can also arise secondary to systemic diseases. Metabolic disorders like Wilson's disease, characterized by copper accumulation, may manifest as chorea or dystonia. Inflammatory conditions such as rheumatoid arthritis and systemic lupus erythematosus can result in secondary movement disorders due to autoimmune-mediated processes affecting the central nervous system. Movement disorders linked to drugs or systemic diseases often necessitate a thorough clinical evaluation, including detailed medication histories and comprehensive systemic assessments. Neuroimaging, laboratory investigations, and, in some cases, cerebrospinal fluid analyses and electrodiagnostic studies help in establishing accurate diagnoses. Management involves addressing the underlying cause, modifying medications, and employing symptomatic treatments.

show abstract

Section: Cerebral Venous Sinus Thrombosismentioning

confidence: 99%

A Literature Review of Movement Disorder Associated with Medications and Systemic Diseases

Pitton Rissardo,

Fornari Caprara

2024

Preprint

View full text Add to dashboard Cite

show abstract

“…previously, any process that affects the intracranial region may lead to lesions in more than one cranial nerve (CN) or structure, and when this occurs, the clinical presentation could be complex, causing a delay in the diagnosis. [2] One example of this complexity is the isolated Horner's syndrome secondary to rhinosinusitis, which can be explained by Raeder syndrome affecting the third neuron of the oculosympathetic pathway. [3] The sellar region includes the sella turcica and the pituitary gland (adenohypophysis and neurohypophysis); on the other hand, the parasellar region comprizes the cavernous sinuses, suprasellar cistern, hypothalamus, and ventral inferior third ventricle.…”

Section: Letter To Editormentioning

confidence: 99%